Table 7.
Authors | Survival indicators |
---|---|
Worse prognosis | |
Egan, 1982 [15] | Mortality ↑ |
Dabakuyo, 2008 [16] | Mortality ↑ |
5 and 10-year survival ↓ | |
Yerushalmi, 2009 [9] | Survival rate slightly ↓ |
Boyages, 2010 [17] | Mortality rate ↑ |
5 and 10-year survival ↓ | |
Weissenbacher, 2010 [4] | Mean survival ↑ |
↑ Local recurrence rate | |
↑ rate of distant metastases | |
Tot, 2011 [5] | ↑ risk of death due to breast carcinoma |
Ustaalioglu, 2012 [20] | ↓ Disease free survival |
Wolters, 2013 [28] | ↓ Recurrence free survival |
Pekar, 2013 [29] | ↓ Breast Cancer Specific Survival |
No influence on prognosis (no statistically significant differences between compared groups) | |
Vlastos, 2000 [30] | Breast Cancer Specific Survival at 10 years |
Disease-Free Survival | |
Middleton, 2002 [31] | Disease-Free Survival at 5 and 10 years |
Oh, 2006 [32] | Overal Survival at 5 years |
Litton, 2007 [19] | Overal Survival, Relapse-Free Survival |
Joergensen, 2008 [11] | Overal Survival |
Cabioglu, 2009 [33] | Disease-Free Survival at 5 years |
Rezo, 2011 [7] | Overal Survival, Progression Free Survival |
Lynch, 2012 [6] | Relapse-Free Survival, Breast Cancer Specific Survival-worse prognosis at 5 years (only in UVA, not in MVA-other factors are associated with ↓ survival rates |
Abbreviations: UVA - univariate analysis, MVA - multivariate analysis.